Belgium 2019 Belgium Grant Winner
Gut Microbiota in Human Health and Diseases
Ghent University trial in Parkinson’s with faecal transplantation
Given the strong scientific preclinical and clinical data indicating the potential of microbiota-altering therapies for PD are promising, and the anecdotal (case study) evidence that FMT works for these patients, there is an urgent need to reliably test this potential therapy in a randomized clinical trial.
Our study will be the first worldwide to investigate the potential therapeutic effect of FMT on symptoms and disease progression in patients with PD in a double-blind, placebo-controlled randomized clinical trial (source: clinicaltrials.gov).